Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
433.93
-12.35 (-2.77%)
At close: Nov 17, 2026, 4:00 PM EST
434.05
+0.12 (0.03%)
After-hours: Nov 17, 2026, 7:56 PM EST
Elevance Health Revenue
Elevance Health had revenue of $50.44B in the quarter ending September 30, 2026, with 0.70% growth. This brings the company's total for the last twelve months to $199.07B, up 3.01% year-over-year. In the year 2025, Elevance Health had annual revenue of $197.58B with 12.77% growth. That makes Elevance Health the 29th largest company in the world by revenue and 17th in the United States.
Revenue (ttm)
$199.07B
Revenue Growth
+3.01%
P/S Ratio
0.46
Revenue / Employee
$2,078,599
Employees
97,100
Market Cap
93.75B
Revenue by Segment
- Health Benefits 167.09B 69.8%
- CarelonRx 43.40B 18.1%
- Carelon Services 28.32B 11.8%
- Corporate & Other 463.00M 0.2%
Fiscal year ended Dec 31, 2025 See the full Elevance Health breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 197.58B | 22.38B | 12.77% |
| Dec 31, 2024 | 175.20B | 5.00B | 2.93% |
| Dec 31, 2023 | 170.21B | 14.55B | 9.35% |
| Dec 31, 2022 | 155.66B | 18.72B | 13.67% |
| Dec 31, 2021 | 136.94B | 16.14B | 13.36% |
| Dec 31, 2020 | 120.81B | 17.67B | 17.13% |
| Dec 31, 2019 | 103.14B | 11.80B | 12.92% |
| Dec 31, 2018 | 91.34B | 2.28B | 2.56% |
| Dec 31, 2017 | 89.06B | 4.87B | 5.78% |
| Dec 31, 2016 | 84.19B | 5.79B | 7.38% |
| Dec 31, 2015 | 78.40B | 5.38B | 7.37% |
| Dec 31, 2014 | 73.02B | 2.83B | 4.03% |
| Dec 31, 2013 | 70.19B | 9.68B | 15.99% |
| Dec 31, 2012 | 60.51B | 648.80M | 1.08% |
| Dec 31, 2011 | 59.87B | 2.12B | 3.68% |
| Dec 31, 2010 | 57.74B | -3.00B | -4.94% |
| Dec 31, 2009 | 60.74B | -839.20M | -1.36% |
| Dec 31, 2008 | 61.58B | 1.42B | 2.37% |
| Dec 31, 2007 | 60.16B | 3.98B | 7.08% |
| Dec 31, 2006 | 56.18B | 12.19B | 27.71% |
| Dec 31, 2005 | 43.99B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 450.06B |
| CVS Health | 418.16B |
| The Cigna Group | 286.32B |
| Centene | 180.41B |
| Humana | 154.19B |
| Molina Healthcare | 42.08B |
| Oscar Health | 17.47B |
| Alignment Healthcare | 4.94B |
ELV News
- 13 hours ago - From Confusion to Clarity: Consumers See a Role for AI in Simplifying Healthcare, Elevance Health/Harris Poll Survey Finds - Business Wire
- 5 days ago - AM Best Assigns Indicative Issue Credit Ratings to Elevance Health, Inc.'s New Shelf Registration - Business Wire
- 6 days ago - Elevance Health Transcript: UBS Global Healthcare Conference - Transcripts
- 7 days ago - Elevance to reaffirm FY26 adjusted EPS view at least $29.00, consensus $29.14 - TheFly
- 12 days ago - Insurer Sues Autism-Therapy Provider Over $160 Million in Allegedly Misleading Claims - WSJ
- 20 days ago - Elevance Health files automatic mixed securities shelf - TheFly
- 22 days ago - Tennessee rate news positive for Elevance, UnitedHealth, says Evercore ISI - TheFly
- 25 days ago - Elevance Health price target raised to $495 from $465 at TD Cowen - TheFly